Federal Register: February 24, 2003 (Volume 68, Number 36)
DOCID: FR Doc 03-4215
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
NOTICE: NOTICES
ACTION: Meetings:
SUBJECT CATEGORY:
National Heart, Lung, and Blood Institute; Notice of Closed Meeting
DOCUMENT SUMMARY:
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel, Stem Cell Biology and CellBased Therapies of Heart, Blood and Sleep Disorders.
Date: March 1011, 2003.
Time: 8 am to 5 pm.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Robert B Moore, PhD, Review Branch, Division of
Extramural Affairs, National Heart, Lung, and Blood Institute,
National Institutes of Health, 6701 Rockledge Drive, Room 7178, MSC 7924, Bethesda, MD 20892, 301/4350725.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838; Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of Health, HHS)
Dated: February 12, 2003.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 034215 Filed 22103; 8:45 am]
BILLING CODE 414001M
SUMMARY:
National Heart, Lung, and Blood Institute,
DOCUMENT BODY 2:
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel, Stem Cell Biology and CellBased Therapies of Heart, Blood and Sleep Disorders.
Date: March 1011, 2003.
Time: 8 am to 5 pm.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Robert B Moore, PhD, Review Branch, Division of
Extramural Affairs, National Heart, Lung, and Blood Institute,
National Institutes of Health, 6701 Rockledge Drive, Room 7178, MSC 7924, Bethesda, MD 20892, 301/4350725.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838; Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of Health, HHS)
Dated: February 12, 2003.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 034215 Filed 22103; 8:45 am]
BILLING CODE 414001M